60 Recruiting Prostate Cancer Phase 2 Clinical Trials
Active phase 2 studies for prostate cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Prostate Cancer studiesPhase 2 Studies for Prostate Cancer
A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer
π Memorial Sloan Kettering Basking Ridge (All Protocol Activities) β Basking Ridge, New Jersey
View Study & Checklist βA Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer
π St. Joseph's Hospital and Medical Center β Phoenix, Arizona
View Study & Checklist βNeoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer
π Johns Hopkins Sidney Kimmel Comprehensive Cancer Center β Baltimore, Maryland
View Study & Checklist βA Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer
π Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) β Basking Ridge, New Jersey
View Study & Checklist βRandomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks
π Weill Cornell Medicine β New York, New York
View Study & Checklist βFirst Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer
π Moffitt Cancer Center β Tampa, Florida
View Study & Checklist βStudy of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer
π SKCCC β Baltimore, Maryland
View Study & Checklist βHuman Amnion Membrane Allograft and Early Return of Erectile Function After Radical Prostatectomy
π University of Miami β Miami, Florida
View Study & Checklist βSunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy
π University of Texas MD Anderson Cancer Center β Houston, Texas
View Study & Checklist βEBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer
π University of Virginia β Charlottesville, Virginia
View Study & Checklist βMultimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy
π University of Texas MD Anderson Cancer Center β Houston, Texas
View Study & Checklist βA Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer
π Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) β Basking Ridge, New Jersey
View Study & Checklist β177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer
π Tom Baker Cancer Centre β Calgary, Alberta
View Study & Checklist βA Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer
π Levine Cancer Institute β Charlotte, North Carolina
View Study & Checklist βAndrogen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer
π University of Wisconsin Carbone Cancer Center β Madison, Wisconsin
View Study & Checklist βSacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy
π Memorial Sloan-Kettering Cancer Center β New York, New York
View Study & Checklist βStudy of TGF-Ξ² Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer
π Sibley Memorial Hospital β Washington D.C., District of Columbia
View Study & Checklist βNeoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer
π University of California, Los Angeles β Los Angeles, California
View Study & Checklist βThe Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancer
π Memorial Sloan Kettering Cancer Center β New York, New York
View Study & Checklist βRandomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
π Foothills Urology β Golden, Colorado
View Study & Checklist βTargeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)
π University of Michigan Hospital β Ann Arbor, Michigan
View Study & Checklist βpTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer
π University of Wisconsin Carbone Cancer Center β Madison, Wisconsin
View Study & Checklist βStudy of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations
π University of California San Diego - Moores Cancer Center β La Jolla, California
View Study & Checklist βPhase I Dose-escalation Study of Fractionated 177Lu-PSMA-617 for Progressive Metastatic CRPC
π Tulane Cancer Center Clinic β New Orleans, Louisiana
View Study & Checklist βStudy of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer
π Moffitt Cancer Center β Tampa, Florida
View Study & Checklist βHigh-Risk Metachronous Oligometastatic Prostate Cancer Trial
π University of Maryland Greenebaum Cancer Center β Baltimore, Maryland
View Study & Checklist βEffects of EPA on Prostate Cancer Cells Proliferation and Quality of Life
π Centre de Recherche Clinique et Evaluative en Oncologie - Hotel Dieu de Quebec β QuΓ©bec, Quebec
View Study & Checklist βPSMA-PET Guided Radiotherapy
π CSSSL - CitΓ© de la SantΓ© Laval β Laval, Quebec
View Study & Checklist βIntermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer
π Odette Cancer Centre β Toronto, Ontario
View Study & Checklist β177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer
π Cedars Sinai β Los Angeles, California
View Study & Checklist βProstate Cancer Biomarker Enrichment and Treatment Selection
π Cross Cancer Institute β Edmonton, Alberta
View Study & Checklist βClinical Trial of Green Tea Catechins in Men on Active Surveillance
π Moffitt Cancer Center β Tampa, Florida
View Study & Checklist βHypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer
π Tom Baker Cancer Centre β Calgary, Alberta
View Study & Checklist βMulti-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy
π London Health Sciences Centre β London, Ontario
View Study & Checklist βINTREPId (INTermediate Risk Erection PreservatIon Trial)
π Stamford Hospital β Stamford, Connecticut
View Study & Checklist βEvaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy
π Memorial Sloan Kettering Basking Ridge β Basking Ridge, New Jersey
View Study & Checklist βPhase II Study of Pencil Beam Scanning Proton Stereotactic Body Radiation Therapy for Prostate Cancer
π The New York Proton Center β New York, New York
View Study & Checklist βBrachytherapy for Prostatic Carcinoma Patients
π University of Texas MD Anderson Cancer Center β Houston, Texas
View Study & Checklist βA Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery
π Arizona Center for Cancer Care - Gilbert β Gilbert, Arizona
View Study & Checklist βEffects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer.
π Centre de Recherche Clinique et Γvaluative en Oncologie - HΓ΄tel-Dieu de QuΓ©bec β QuΓ©bec, Quebec
View Study & Checklist βA Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer
π University of Michigan Rogel Cancer Center β Ann Arbor, Michigan
View Study & Checklist βNivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer
π St. Elizabeth's Medical Center β Boston, Massachusetts
View Study & Checklist βCombination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy
π H. Lee Moffitt Cancer Center and Research Institute β Tampa, Florida
View Study & Checklist βA Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
π Site US10052 β Anchorage, Alaska
View Study & Checklist βPalbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer
π QEII Health Sciences Centre β Halifax, Nova Scotia
View Study & Checklist βFocal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)
π University of Michigan Rogel Cancer Center β Ann Arbor, Michigan
View Study & Checklist βCombining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naΓ―ve Patients With Progressive Metastatic Castration-resistant Prostate Cancer
π Northwestern University β Evanston, Illinois
View Study & Checklist βMulti-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma
π University of Chicago β Chicago, Illinois
View Study & Checklist βAMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft
π Hackensack University Medical Center β Hackensack, New Jersey
View Study & Checklist βPharmacogenomics IND Commercial SNP Clinical Study - Abiraterone and Single Nucleotide Polymorphisms
π Medicine Invention Design, Inc. - IORG0007849 - NPI-1023387701 β Rockville, Maryland
View Study & Checklist βBiomarkers for Neoadjuvant Pembrolizumab in Non-Metastatic Prostate Cancer Positive by 18FDG-PET Scanning
π CHU de QuΓ©bec-UniversitΓ© Laval β QuΓ©bec,
View Study & Checklist βTrial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
π Northewestern University β Chicago, Illinois
View Study & Checklist βNivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)
π Winship Cancer Institute, Emory University β Atlanta, Georgia
View Study & Checklist βProstate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer
π Tulane University β New Orleans, Louisiana
View Study & Checklist βComeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)
π Beth Israel Deaconess Medical Center β Boston, Massachusetts
View Study & Checklist βDetecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.
π CHUM β Montreal, Quebec
View Study & Checklist βFolate Study in Men With Advanced Prostate Cancer
π University of California, San Diego β La Jolla, California
View Study & Checklist βSacituzumab Tirumotecan in Pts w/ NEPC After Progression on Prior Chemotherapy
π Virginia Commonwealth University β Richmond, Virginia
View Study & Checklist βWhole Versus Partial Gland Boost During Prostate SBRT
π Fred & Pamela Buffet Cancer Center β Omaha, Nebraska
View Study & Checklist βRadiation Treatment of the Prostate That is Specially Adjusted for Each Person
π Jack Ady Cancer Centre β Lethbridge, Alberta
View Study & Checklist β